Summit Therapeutics Inc. Common Stock

SMMTNasdaq · USD · StocksQuote as of 2026-09-17· Exchange session not verified

$17.70

+2.34%

Today

Next earnings call

In 31 days

2026-10-19

Fiscal period

Q3 2026

EPS estimate

— / (-$0.28 est.)

Revenue estimate

— / (— est.)

Timing

unknown

EPS vs. consensus estimate

Actual
Estimate

Q1 25Q2 25Q3 25Q4 25Q 25Q1 26Q 26Q2 26

Revenue vs. consensus estimate

Actual
Estimate

Q3 23Q4 23Q3 24Q2 25Q3 25Q4 25Q1 26Q2 26

EPS surprise history

Q 25Q 26

Beat or met consensus in 0% of the last 2 reported quarters.

Previous reports

Values are converted from USD into your selected display currency. Actuals are drawn from SEC filings (XBRL) and Yahoo statements; estimates and surprises from Nasdaq where available.

Fiscal period	Report date	Normalized EPS	EPS surprise	Revenue	Rev. surprise	Actions
Q2 2026	Jul 23, 2026	-$0.28 / (— est.)	—	$0.00 / (— est.)	—	Source
Q 2026	Jul 23, 2026	-$0.28 / (-$0.26 est.)	-7.69%	0 (unit unavailable) / (— est.)	—	Source
Q1 2026	Apr 30, 2026	-$0.24 / (— est.)	—	$0.00 / (— est.)	—	Source
Q 2025	Feb 23, 2026	-$0.29 / (-$0.22 est.)	-31.82%	0 (unit unavailable) / (— est.)	—	Source
Q4 2025	Jan 12, 2026	-$0.29 / (— est.)	—	$0.00 / (— est.)	—	Source
Q3 2025	Oct 20, 2025	-$0.31 / (— est.)	—	$0.00 / (— est.)	—	Source
Q2 2025	Aug 11, 2025	-$0.76 / (— est.)	—	$0.00 / (— est.)	—	Source
Q1 2025	May 1, 2025	-$0.09 / (— est.)	—	— / (— est.)	—	Source
Q4 2024	Jan 13, 2025	-0.08 (unit unavailable) / (— est.)	—	— / (— est.)	—	Source
Q3 2024	Oct 30, 2024	-$0.08 / (— est.)	—	$0.00 / (— est.)	—	Source
Q2 2024	Aug 6, 2024	-$0.09 / (— est.)	—	— / (— est.)	—	Source
Q1 2024	May 1, 2024	-$0.06 / (— est.)	—	— / (— est.)	—	Source
Q4 2023	Jan 8, 2024	0.49 (unit unavailable) / (— est.)	—	$0.00 / (— est.)	—	Source
Q3 2023	Nov 7, 2023	-$0.03 / (— est.)	—	$0.00 / (— est.)	—	Source
Q2 2023	Aug 2, 2023	-$0.02 / (— est.)	—	$0.00 / (— est.)	—	Source
Q1 2023	May 11, 2023	-$1.43 / (— est.)	—	$0.00 / (— est.)	—	Source
Q4 2022	Jan 9, 2023	-0.04 (unit unavailable) / (— est.)	—	$0.00 / (— est.)	—	Source
Q3 2022	Nov 9, 2022	-$0.10 / (— est.)	—	$220K / (— est.)	—	Source
Q2 2022	Aug 2, 2022	-$0.12 / (— est.)	—	$235K / (— est.)	—	Source
Q1 2022	May 11, 2022	-$0.15 / (— est.)	—	$250K / (— est.)	—	Source
Q4 2021	Mar 17, 2022	0.01 (unit unavailable) / (— est.)	—	$251K / (— est.)	—	Source
Q3 2021	Nov 15, 2021	-$0.20 / (— est.)	—	$1.3M / (— est.)	—	Source
Q2 2021	Aug 11, 2021	-$0.27 / (— est.)	—	$57K / (— est.)	—	Source
Q1 2021	May 17, 2021	-$0.21 / (— est.)	—	$192K / (— est.)	—	Source
Q4 2020	Mar 17, 2021	-0.18 (unit unavailable) / (— est.)	—	$185K / (— est.)	—	Source
Q3 2020	Nov 16, 2020	-$0.26 / (— est.)	—	$181K / (— est.)	—	Source
Q2 2020	Sep 29, 2020	-$0.23 / (— est.)	—	$170K / (— est.)	—	Source